M3DICINE Inc, designers of intelligent medical devices has announced the launch of Stethee, the world’s first AI enabled stethoscope system. With a revolutionary new design that works as easily as a traditional stethoscope, the Stethee family of products allows users to listen to heart and lungs sounds with sophisticated amplification and filtering technology and to instantly capture and analyze heart and lung sounds and data via Bluetooth to the Stethee iOS or Android App providing a whole new level of diagnostics capabilities.
Stethoscope System Product Overview
The Stethee system is comprised of three core products:
– The FDA Cleared Stethee Pro for medical and healthcare professionals
– Stethee Vet for veterinarians and animal professionals
– Stethee Edu developed specifically as an education and research tool.
How It Works
In 20 seconds (or less), the new stethoscope delivers what a traditional stethoscope never will — clinically validated and accurately, verified, comparable and shareable biometrics and clinical data for a higher quality of patient care. The technology platform behind the Stethee AI engine, named “Aida,” can analyze heart and lung sounds to build a unique personal biometric signature. The data is represented in real time in the Stethee App for easy understanding of vital signs, and can be easily shared with peers, caregivers or specialists anywhere in the world.
Aida also automatically tags geo-location and environmental data to each sample in real-time. This provides a completely new dimension of data analytics for public health planning to understand what effects environmental factors like humidity, temperature, pollen count or pollution have on our heart and lungs. Aida analyzes this encrypted and anonymized data in order learn and report back quantitative clinically actionable data to doctors, vets, and healthcare professionals.
To develop the new stethoscope, M3DICINE worked closely with an international team of specialists, designers and engineers from MIT, clinical experts from the Mayo Clinic as well as cardiologists, nurses and allied health professionals from the UK, Malaysia, Singapore and Australia. The entire development process of the Stethee System has adhered to the highest international design and safety standards and US FDA.
Partnerships & Distribution
M3DICINE has signed exclusive agreements with Korea Telecom for the distribution of Stethee Pro for telemedicine projects into a number of developing countries and an exclusive distribution agreement with Cargill Korea for Stethee Vet to veterinarians in South Korea.
Pricing & Availability
Stethee Pro and Stethee Vet are now available for online for pre-order for $499 and units will begin shipping in late February. Stethee Edu for education and research will be available summer 2018. Advanced AI-driven analytics and insights are available through Stethee Central, a subscription based web portal. Stethee Pro and Stethee Vet App will be available for download from the Apple Store and Google Play store.
“The Stethee system has the potential to transform healthcare,” said Professor John Sperling, M.D., Vice-Chair, Department of Orthopedic Surgery MAYO Clinic in a statement. “We are on the forefront of a new era in healthcare driven by artificial intelligence and its ability to significantly improve our ability to care for patients. This innovative technology can significantly help drive efficiency and productivity and empower healthcare providers worldwide by providing real time data and clinical interpretation.
M3DICINE Pty Ltd is backed by an initial financing round of $4.5 million from private investors including Pond Capital and, more recently, the Board has approved the raise of a $2.5 million convertible note managed by Pond Capital. Funds from the new note will support product development, sales and marketing, as well as building out service capabilities.